Novartis does not recommend the use of its products in unapproved indications and recommends to refer to complete prescribing information prior to using any of the Novartis products.
Please note that the content of the SYBRAVA (inclisiran) Patient Support Program is the property of Zyla Health Private Limited. Novartis Healthcare Private Limited has no say on the accuracy, completeness, currency of any information and shall not be responsible or in any way liable for any errors, omissions or inaccuracies in such information. Novartis does not assume any liability and will not be responsible or held liable in any manner whatsoever for any decision made, action or non-action taken in reliance upon the information provided on the Zyla application.